Histone deacetylase 6 inhibition restores autophagic flux to promote functional recovery after spinal cord injury

Exp Neurol. 2020 Feb:324:113138. doi: 10.1016/j.expneurol.2019.113138. Epub 2019 Nov 30.

Abstract

After spinal cord injury (SCI), the inhibitory molecules derived from scars at the lesion sites and the limited regenerative capacity of neuronal axons pose difficulties for the recovery after SCI. Remodeling of cytoskeleton structures including microtubule assembly and tubulin post-translational modification are widely accepted to play a crucial role in initiation of growth cone and regrowth of injured axon. Although increasing studies have focused on the association between tubulin acetylation and autophagy due to the role of tubulin acetylation in organelles and substances transport, there are no studies exploring the effect of tubulin acetylation on autophagy after spinal cord injury (SCI). Here, we found that histone deacetylase 6 (HDAC6) was significantly up-regulated after SCI, while inhibition of HDAC6 by Tubastatin A induced functional recovery after SCI. In view of enzyme-dependent and -independent mechanisms of HDAC6 to adjust diverse cellular processes, such as autophagy, the ubiquitin proteasome system and post-translational modification of tubulin, we mainly focused on the significance of HDAC6 in axonal regeneration and autophagy after SCI. Western blotting, Co-immunoprecipitation and immunofluorescence staining were conducted to showed that Tubastatin A treatment in nocodazole-treated cells and mice suffering from SCI prompted acetylation and stabilization of microtubules and thus restored transport function, which may contribute to restored autophagic flux and increased axonal length. Whereas inhibition of degradation of autolysosomes by bafilomycin A1 (Baf-A1) reversed functional recovery caused by Tubastatin A, revealing the association between tubulin acetylation and autophagy, which supports HDAC6 inhibition as a potential target for SCI treatment.

Keywords: Autophagy; Deacetylation; HDAC6; Microtubule system; Spinal cord injury.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autophagy / drug effects*
  • Axonal Transport / drug effects
  • Axons / drug effects
  • Axons / pathology
  • Enzyme Inhibitors / pharmacology
  • Histone Deacetylase 6 / antagonists & inhibitors*
  • Histone Deacetylase Inhibitors / therapeutic use*
  • Hydroxamic Acids / antagonists & inhibitors
  • Hydroxamic Acids / therapeutic use*
  • Indoles / antagonists & inhibitors
  • Indoles / therapeutic use*
  • Locomotion
  • Macrolides / pharmacology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Microtubules / drug effects
  • Nerve Regeneration / drug effects
  • Nocodazole / pharmacology
  • PC12 Cells
  • Rats
  • Recovery of Function*
  • Spinal Cord Injuries / drug therapy*
  • Spinal Cord Injuries / pathology*

Substances

  • Enzyme Inhibitors
  • Histone Deacetylase Inhibitors
  • Hydroxamic Acids
  • Indoles
  • Macrolides
  • tubastatin A
  • bafilomycin A1
  • Hdac6 protein, mouse
  • Histone Deacetylase 6
  • Nocodazole